2-Fluoro-5-(trifluoromethyl)pyridine → (2-Fluoro-3-methoxy-6-(2H-1,2,3-triazol-2-yl)phenyl)((2S,3R)-3-methyl-2-(((5-(trifluoromethyl)pyridin-2-yl)amino)methyl)piperidin-1-yl)methanone
Reaction equation
[F:1][C:2]1[C:10]([O:11][CH3:12])=[CH:9][CH:8]=[C:7]([N:13]2[N:17]=[CH:16][CH:15]=[N:14]2)[C:3]=1[C:4]([OH:6])=O.[CH3:18][C@@H:19]1[CH2:24][CH2:23][CH2:22][NH:21][C@@H:20]1[CH2:25][N:26]1C(=O)C2C(=CC=CC=2)C1=O.F[C:38]1[CH:43]=[CH:42][C:41]([C:44]([F:47])([F:46])[F:45])=[CH:40][N:39]=1>>[F:1][C:2]1[C:10]([O:11][CH3:12])=[CH:9][CH:8]=[C:7]([N:13]2[N:17]=[CH:16][CH:15]=[N:14]2)[C:3]=1[C:4]([N:21]1[CH2:22][CH2:23][CH2:24][C@@H:19]([CH3:18])[C@H:20]1[CH2:25][NH:26][C:38]1[CH:43]=[CH:42][C:41]([C:44]([F:47])([F:46])[F:45])=[CH:40][N:39]=1)=[O:6]Participants
4
Reactant 3
Product 1
Procedure
The title compound was prepared following the same general protocol as described in Example A1, using 2-fluoro-3-methoxy-6-(2H-1,2,3-triazol-2-yl)benzoic acid, 2-(((2S,3R)-3-methylpiperidin-2-yl)methyl)isoindoline-1,3-dione and 2-fluoro-5-(trifluoromethyl)pyridine. ESI-MS (m/z): 493 [M+1]+. 1H NMR (500 MHz, DMSO-d6) δ 8.40-6.45 (m, 8H), 4.85-2.70 (m, 8H), 1.85-0.65 (m, 8H).
Sources & evidence
- ORD record
- ord-f18f51b5d1f8407e86f73ec475d2d18b
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09440982B2
Reaction notes
Loading…